<DOC>
	<DOCNO>NCT02282657</DOCNO>
	<brief_summary>Pathophysiological , experimental clinical data suggest ' '' ultraprotective '' mechanical ventilation strategy may reduce VILI ARDS-associated morbidity mortality . Severe hypercapnia induce VT reduction set might efficiently control ECCO2R device . A proof-of-concept study conduct limited number ARDS case indicate ECCO2R allow VT reduction 3.5-5 ml/kg achieve Pplat &lt; 25 cm H2O may reduce VILI .</brief_summary>
	<brief_title>Strategy UltraProtective Lung Ventilation With Extracorporeal CO2 Removal New-Onset Moderate seVere ARDS</brief_title>
	<detailed_description>Over past decade , highly significant progress make understand pathophysiology acute respiratory distress syndrome ( ARDS ) . Recognition ventilation-induced lung injury ( VILI ) lead radical modification ventilatory management patient . The landmark trial ARDSnet trial group demonstrate 2000 ventilating ARDS patient low tidal volume ( VT ) 6 ml/kg ( calculate predict body weight ) , maximum end-inspiratory plateau pressure ( Pplat ) 30 cmH2O decrease mortality 39.8 % ( conventional arm treat VT 12 ml/kg PBW ) 31 % . However , recent study show lung hyperinflation still occur approximately 30 % ARDS patient even though ventilate use ARDSNet strategy . Additionally , Hager coworkers find mortality decrease Pplat decline high low level level Pplat data collect `` ARDSNet '' trial group . Their analysis suggest beneficial effect VT reduction even patient already Pplat &lt; 30 cm H2O VT reduction.Similar observation also recently report Needham et al cohort 485 patient ARDS . Because VT reduction &lt; 6 ml/kg achieve low Pplat may induce severe hypercapnia may cause elevated intracranial pressure , pulmonary hypertension , decrease myocardial contractility , decrease renal blood flow , release endogenous catecholamine , strategy use `` ultraprotective '' MV setting possible patient conventional mechanical ventilation moderate severe ARDS . Extracorporeal carbon dioxide removal ( ECCO2R ) may use association mechanical ventilation permit VT reduction &lt; 6 ml/kg achieve low Pplat ( 20-25 cm H2O ) . In observational study conduct 80 's , Gattinoni show use venovenous ECCO2R flow 1.5-2.5 l/min addition quasi apneic mechanical ventilation peak inspiratory pressure limit 35-45 cmH2O PEEP set 15-25 cmH2O result low expect mortality observational cohort severe ARDS patient . However , randomize , control single-center study use technology conduct 1990s Morris 's group Utah stop early futility 40 patient enrol failed demonstrate mortality benefit device ( 58 % control group vs. 70 % treatment group ) . In recent year , new-generation ECCO2R device develop . They offer low resistance blood flow , small prim volumes much effective gas exchange . With ECCO2R patient 's PaCO2 principally determine rate fresh gas flow membrane lung . In ECCO2R animal model , CO2 removal average 72±1.2 mL/min blood flow 450 mL/min , CO2 production lung decrease 50 % reduction minute ventilation 5.6 L/min baseline 2.6 L/min insertion device . Lastly , Terragni et al ( 15 ) demonstrate ECCO2R could improve pulmonary protection allow low tidal volume ventilation ( 3.5-5 ml/kg PBW ) proof-of-concept study ten patient ARDS . This strategy also associate significant decrease pulmonary inflammatory biomarkers .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>Mechanical ventilation expect duration &gt; 24h Moderate ARDS accord Berlin definition ( 16 ) PaO2/FiO2 : 200100 mmHg , PEEP ≥ 5 cmH2O Age &lt; 18 year Pregnancy Decompensated heart insufficiency acute coronary syndrome Severe COPD Major respiratory acidosis PaCO2 &gt; 60 mmHg Acute brain injury Severe liver insufficiency ( ChildPugh score &gt; 7 ) fulminant hepatic failure Heparininduced thrombocytopenia Contraindication systemic anticoagulation Patient moribund , decision limit therapeutic intervention Catheter access femoral vein jugular vein impossible Pneumothorax Platelet &lt; 50 G/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>extracorporreal</keyword>
	<keyword>CO2 removal</keyword>
	<keyword>ARDS</keyword>
	<keyword>lung</keyword>
	<keyword>Protective ventilation</keyword>
</DOC>